EBAC
European Biotech Acquisition Corp. Class A Ordinary Shares
EBAC
EBAC
Delisted
EBAC was delisted on the 2nd of March, 2023.
0 hedge funds and large institutions have $0 invested in European Biotech Acquisition Corp. Class A Ordinary Shares in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 50 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
–
Holders Change
-50
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
50
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
1 |
GCL
Glazer Capital LLC
New York
|
-$12.7M |
2 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
-$7.85M |
3 |
Millennium Management
New York
|
-$5.99M |
4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$5.09M |
5 |
LA
Linden Advisors
New York
|
-$5.03M |